Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 5.1B | 5.6B | 5.0B | 4.8B |
Cost of revenue | 2.8B | 2.9B | 2.7B | 2.6B |
Gross profit | 2.3B | 2.6B | 2.3B | 2.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.1B | 1.0B | 1.0B | 926.7M |
Other operating expenses | — | — | — | — |
Operating income | 1.2B | 1.6B | 1.3B | 1.3B |
Non operating interest income | ||||
Income | 88M | 55.9M | 83.9M | 91.7M |
Expense | 113.7M | 74.8M | 129.6M | 137.8M |
Other income expense | 9.6M | 7.8M | 7.2M | 10M |
Pretax income | 1.2B | 1.6B | 1.3B | 1.2B |
Tax provision | 280M | 372.4M | 298.1M | 279.9M |
Net income | 910.7M | 1.2B | 963.2M | 956.3M |
Basic EPS | — | 3.1 | 2.4 | 2.3 |
Diluted EPS | — | 3.1 | 2.4 | 2.3 |
Basic average shares | — | 406.9M | 407.6M | 407.9M |
Diluted average shares | — | 408.5M | 409M | 409.5M |
EBITDA | 1.4B | 1.8B | 1.5B | 1.5B |
Net income from continuing op. | 910.7M | 1.2B | 963.2M | 956.3M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |